 | • レポートコード：QFJ1-4273 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、バセドウ病の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗甲状腺剤、ロジン＆ロディド、放射性ロジン、ロニック阻害剤）、用途別市場規模（病院薬局、オンライン薬局、小売店薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・バセドウ病の市場動向 ・企業の競争状況、市場シェア ・バセドウ病の種類別市場規模と予測2016-2027（抗甲状腺剤、ロジン＆ロディド、放射性ロジン、ロニック阻害剤） ・バセドウ病の用途別市場規模と予測2016-2027（病院薬局、オンライン薬局、小売店薬局） ・バセドウ病の北米市場規模2016-2027（アメリカ、カナダ） ・バセドウ病の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・バセドウ病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バセドウ病の中南米市場規模2016-2027（メキシコ、ブラジル） ・バセドウ病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、GlaxoSmithKline plc、Merck & Co、Pfizer, Inc、RLC LABS、AbbVie, Inc、Mylan N.V、Allergan, plc） ・結論 |
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism.
Market Analysis and Insights: Global Graves Disease Market
The global Graves Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Graves Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Graves Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Graves Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Graves Disease market.
Global Graves Disease Scope and Market Size
Graves Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Graves Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-Thyroid Drugs
Lodine &Lodides
Radioactive Lodine
Lonic Inhibitors
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Graves Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Thyroid Drugs
1.2.3 Lodine &Lodides
1.2.4 Radioactive Lodine
1.2.5 Lonic Inhibitors
1.3 Market by Application
1.3.1 Global Graves Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Graves Disease Market Perspective (2016-2027)
2.2 Graves Disease Growth Trends by Regions
2.2.1 Graves Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Graves Disease Historic Market Share by Regions (2016-2021)
2.2.3 Graves Disease Forecasted Market Size by Regions (2022-2027)
2.3 Graves Disease Industry Dynamic
2.3.1 Graves Disease Market Trends
2.3.2 Graves Disease Market Drivers
2.3.3 Graves Disease Market Challenges
2.3.4 Graves Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Graves Disease Players by Revenue
3.1.1 Global Top Graves Disease Players by Revenue (2016-2021)
3.1.2 Global Graves Disease Revenue Market Share by Players (2016-2021)
3.2 Global Graves Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Graves Disease Revenue
3.4 Global Graves Disease Market Concentration Ratio
3.4.1 Global Graves Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Graves Disease Revenue in 2020
3.5 Graves Disease Key Players Head office and Area Served
3.6 Key Players Graves Disease Product Solution and Service
3.7 Date of Enter into Graves Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Graves Disease Breakdown Data by Type
4.1 Global Graves Disease Historic Market Size by Type (2016-2021)
4.2 Global Graves Disease Forecasted Market Size by Type (2022-2027)
5 Graves Disease Breakdown Data by Application
5.1 Global Graves Disease Historic Market Size by Application (2016-2021)
5.2 Global Graves Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Graves Disease Market Size (2016-2027)
6.2 North America Graves Disease Market Size by Type
6.2.1 North America Graves Disease Market Size by Type (2016-2021)
6.2.2 North America Graves Disease Market Size by Type (2022-2027)
6.2.3 North America Graves Disease Market Size by Type (2016-2027)
6.3 North America Graves Disease Market Size by Application
6.3.1 North America Graves Disease Market Size by Application (2016-2021)
6.3.2 North America Graves Disease Market Size by Application (2022-2027)
6.3.3 North America Graves Disease Market Size by Application (2016-2027)
6.4 North America Graves Disease Market Size by Country
6.4.1 North America Graves Disease Market Size by Country (2016-2021)
6.4.2 North America Graves Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Graves Disease Market Size (2016-2027)
7.2 Europe Graves Disease Market Size by Type
7.2.1 Europe Graves Disease Market Size by Type (2016-2021)
7.2.2 Europe Graves Disease Market Size by Type (2022-2027)
7.2.3 Europe Graves Disease Market Size by Type (2016-2027)
7.3 Europe Graves Disease Market Size by Application
7.3.1 Europe Graves Disease Market Size by Application (2016-2021)
7.3.2 Europe Graves Disease Market Size by Application (2022-2027)
7.3.3 Europe Graves Disease Market Size by Application (2016-2027)
7.4 Europe Graves Disease Market Size by Country
7.4.1 Europe Graves Disease Market Size by Country (2016-2021)
7.4.2 Europe Graves Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Graves Disease Market Size (2016-2027)
8.2 Asia-Pacific Graves Disease Market Size by Type
8.2.1 Asia-Pacific Graves Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Graves Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Graves Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Graves Disease Market Size by Application
8.3.1 Asia-Pacific Graves Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Graves Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Graves Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Graves Disease Market Size by Region
8.4.1 Asia-Pacific Graves Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Graves Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Graves Disease Market Size (2016-2027)
9.2 Latin America Graves Disease Market Size by Type
9.2.1 Latin America Graves Disease Market Size by Type (2016-2021)
9.2.2 Latin America Graves Disease Market Size by Type (2022-2027)
9.2.3 Latin America Graves Disease Market Size by Type (2016-2027)
9.3 Latin America Graves Disease Market Size by Application
9.3.1 Latin America Graves Disease Market Size by Application (2016-2021)
9.3.2 Latin America Graves Disease Market Size by Application (2022-2027)
9.3.3 Latin America Graves Disease Market Size by Application (2016-2027)
9.4 Latin America Graves Disease Market Size by Country
9.4.1 Latin America Graves Disease Market Size by Country (2016-2021)
9.4.2 Latin America Graves Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Graves Disease Market Size (2016-2027)
10.2 Middle East & Africa Graves Disease Market Size by Type
10.2.1 Middle East & Africa Graves Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Graves Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Graves Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Graves Disease Market Size by Application
10.3.1 Middle East & Africa Graves Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Graves Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Graves Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Graves Disease Market Size by Country
10.4.1 Middle East & Africa Graves Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Graves Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Graves Disease Introduction
11.1.4 Abbott Laboratories Revenue in Graves Disease Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Graves Disease Introduction
11.2.4 GlaxoSmithKline plc Revenue in Graves Disease Business (2016-2021)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Graves Disease Introduction
11.3.4 Merck & Co Revenue in Graves Disease Business (2016-2021)
11.3.5 Merck & Co Recent Development
11.4 Pfizer, Inc
11.4.1 Pfizer, Inc Company Details
11.4.2 Pfizer, Inc Business Overview
11.4.3 Pfizer, Inc Graves Disease Introduction
11.4.4 Pfizer, Inc Revenue in Graves Disease Business (2016-2021)
11.4.5 Pfizer, Inc Recent Development
11.5 RLC LABS
11.5.1 RLC LABS Company Details
11.5.2 RLC LABS Business Overview
11.5.3 RLC LABS Graves Disease Introduction
11.5.4 RLC LABS Revenue in Graves Disease Business (2016-2021)
11.5.5 RLC LABS Recent Development
11.6 AbbVie, Inc
11.6.1 AbbVie, Inc Company Details
11.6.2 AbbVie, Inc Business Overview
11.6.3 AbbVie, Inc Graves Disease Introduction
11.6.4 AbbVie, Inc Revenue in Graves Disease Business (2016-2021)
11.6.5 AbbVie, Inc Recent Development
11.7 Mylan N.V
11.7.1 Mylan N.V Company Details
11.7.2 Mylan N.V Business Overview
11.7.3 Mylan N.V Graves Disease Introduction
11.7.4 Mylan N.V Revenue in Graves Disease Business (2016-2021)
11.7.5 Mylan N.V Recent Development
11.8 Allergan, plc
11.8.1 Allergan, plc Company Details
11.8.2 Allergan, plc Business Overview
11.8.3 Allergan, plc Graves Disease Introduction
11.8.4 Allergan, plc Revenue in Graves Disease Business (2016-2021)
11.8.5 Allergan, plc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Graves Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-Thyroid Drugs
Table 3. Key Players of Lodine &Lodides
Table 4. Key Players of Radioactive Lodine
Table 5. Key Players of Lonic Inhibitors
Table 6. Global Graves Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Graves Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Graves Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Graves Disease Market Share by Regions (2016-2021)
Table 10. Global Graves Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Graves Disease Market Share by Regions (2022-2027)
Table 12. Graves Disease Market Trends
Table 13. Graves Disease Market Drivers
Table 14. Graves Disease Market Challenges
Table 15. Graves Disease Market Restraints
Table 16. Global Graves Disease Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Graves Disease Market Share by Players (2016-2021)
Table 18. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Graves Disease as of 2020)
Table 19. Ranking of Global Top Graves Disease Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Graves Disease Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Graves Disease Product Solution and Service
Table 23. Date of Enter into Graves Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Graves Disease Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Graves Disease Revenue Market Share by Type (2016-2021)
Table 27. Global Graves Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Graves Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Graves Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Graves Disease Revenue Market Share by Application (2016-2021)
Table 31. Global Graves Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Graves Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Graves Disease Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Graves Disease Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Graves Disease Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Graves Disease Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Graves Disease Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Graves Disease Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Graves Disease Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Graves Disease Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Graves Disease Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Graves Disease Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Graves Disease Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Graves Disease Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Graves Disease Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Graves Disease Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Graves Disease Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Graves Disease Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Graves Disease Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Graves Disease Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Graves Disease Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Graves Disease Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Graves Disease Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Graves Disease Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Graves Disease Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Graves Disease Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Graves Disease Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Graves Disease Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Graves Disease Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Graves Disease Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Graves Disease Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Graves Disease Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Graves Disease Product
Table 66. Abbott Laboratories Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. GlaxoSmithKline plc Company Details
Table 69. GlaxoSmithKline plc Business Overview
Table 70. GlaxoSmithKline plc Graves Disease Product
Table 71. GlaxoSmithKline plc Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline plc Recent Development
Table 73. Merck & Co Company Details
Table 74. Merck & Co Business Overview
Table 75. Merck & Co Graves Disease Product
Table 76. Merck & Co Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 77. Merck & Co Recent Development
Table 78. Pfizer, Inc Company Details
Table 79. Pfizer, Inc Business Overview
Table 80. Pfizer, Inc Graves Disease Product
Table 81. Pfizer, Inc Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 82. Pfizer, Inc Recent Development
Table 83. RLC LABS Company Details
Table 84. RLC LABS Business Overview
Table 85. RLC LABS Graves Disease Product
Table 86. RLC LABS Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 87. RLC LABS Recent Development
Table 88. AbbVie, Inc Company Details
Table 89. AbbVie, Inc Business Overview
Table 90. AbbVie, Inc Graves Disease Product
Table 91. AbbVie, Inc Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 92. AbbVie, Inc Recent Development
Table 93. Mylan N.V Company Details
Table 94. Mylan N.V Business Overview
Table 95. Mylan N.V Graves Disease Product
Table 96. Mylan N.V Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 97. Mylan N.V Recent Development
Table 98. Allergan, plc Company Details
Table 99. Allergan, plc Business Overview
Table 100. Allergan, plc Revenue in Graves Disease Business (2016-2021) & (US$ Million)
Table 101. Allergan, plc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Graves Disease Market Share by Type: 2020 VS 2027
Figure 2. Anti-Thyroid Drugs Features
Figure 3. Lodine &Lodides Features
Figure 4. Radioactive Lodine Features
Figure 5. Lonic Inhibitors Features
Figure 6. Global Graves Disease Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Graves Disease Report Years Considered
Figure 11. Global Graves Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Graves Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Graves Disease Market Share by Regions: 2020 VS 2027
Figure 14. Global Graves Disease Market Share by Regions (2022-2027)
Figure 15. Global Graves Disease Market Share by Players in 2020
Figure 16. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Graves Disease as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Graves Disease Revenue in 2020
Figure 18. Global Graves Disease Revenue Market Share by Type (2016-2021)
Figure 19. Global Graves Disease Revenue Market Share by Type (2022-2027)
Figure 20. North America Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Graves Disease Market Share by Type (2016-2027)
Figure 22. North America Graves Disease Market Share by Application (2016-2027)
Figure 23. North America Graves Disease Market Share by Country (2016-2027)
Figure 24. United States Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Graves Disease Market Share by Type (2016-2027)
Figure 28. Europe Graves Disease Market Share by Application (2016-2027)
Figure 29. Europe Graves Disease Market Share by Country (2016-2027)
Figure 30. Germany Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Graves Disease Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Graves Disease Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Graves Disease Market Share by Region (2016-2027)
Figure 40. China Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Graves Disease Market Share by Type (2016-2027)
Figure 48. Latin America Graves Disease Market Share by Application (2016-2027)
Figure 49. Latin America Graves Disease Market Share by Country (2016-2027)
Figure 50. Mexico Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Graves Disease Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Graves Disease Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Graves Disease Market Share by Country (2016-2027)
Figure 56. Turkey Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Graves Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 60. GlaxoSmithKline plc Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 61. Merck & Co Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 62. Pfizer, Inc Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 63. RLC LABS Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 64. AbbVie, Inc Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 65. Mylan N.V Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 66. Allergan, plc Revenue Growth Rate in Graves Disease Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の甲状腺眼症治療市場規模・現状・予測（2021年-2027年） Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may…- 世界の小売薬局市場規模・現状・予測（2021年-2027年） A retail pharmacy refers to a retail store of medicines. Market Analysis and Insights: Global Retail Pharmacy Market The global Retail Pharmacy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in…
- 世界の網膜疾患治療薬市場規模・現状・予測（2021年-2027年） Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye. Market Analysis and Insights: Global Retinal Disease Therapeutics Market The global Retinal Disease Therapeutics mark…
- 世界のパーキンソン病治療市場規模・現状・予測（2021年-2027年） Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors s…
- 世界の抗パーキンソン薬市場規模・現状・予測（2021年-2027年） Anti-Parkinson Drugs are drugs used to treat Parkinson's disease. The most commonly used Anti-Parkinson Drugs act on the dopaminergic system of the striatum and basal ganglia, or are central muscarinic antagonists. Market Analysis and Insights: Global Anti-Parkinson Drugs Market The global Anti-Park…